David P. Kennedy - 22 Feb 2023 Form 4 Insider Report for 1Life Healthcare Inc

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Feb 2023, 16:34:46 UTC
Prior SEC filing
18 Jan 2023
Next SEC filing
13 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ivy Tseng, Attorney-in-Fact for David P. Kennedy

Key filing fact

David P. Kennedy filed Form 4 for 1Life Healthcare Inc on 24 Feb 2023.

Key facts

  • This page summarizes David P. Kennedy's Form 4 filing for 1Life Healthcare Inc.
  • 10 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2023, 16:34.

Change

  • Previous filing in this sequence was filed on 18 Jan 2023.
  • Current net transaction value: -$4,699,152.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONEM transaction

Common Stock

Disposed to Issuer

Transaction value
$185,130
Shares
-10,285
Change %
-100%
Price
$18.00
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Footnotes
F1
ONEM transaction

Common Stock

Disposed to Issuer

Transaction value
$4,514,022
Shares
-250,779
Change %
-100%
Price
$18.00
Shares after
0
Date
22 Feb 2023
Ownership
By Trust
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONEM transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-10,462
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,462
Exercise price
$11.47
Footnotes
F3, F4
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-984
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
984
Exercise price
$20.55
Footnotes
F5, F6
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-5,294
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,294
Exercise price
$29.00
Footnotes
F5, F6
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-498
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
498
Exercise price
$40.55
Footnotes
F5, F6
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-676
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
676
Exercise price
$30.48
Footnotes
F5, F6
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-483
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
483
Exercise price
$42.68
Footnotes
F5, F6
ONEM transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-479
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
479
Exercise price
$42.70
Footnotes
F5, F6
ONEM transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-20,728
Change %
-100%
Price
Shares after
0
Date
22 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,728
Exercise price
Footnotes
F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

David P. Kennedy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration").

Footnote F2

Shares held by the Cape Lone Star Trust for which the Reporting Person and his wife are trustees.

Footnote F3

Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes.

Footnote F4

The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option was accelerated in full.

Footnote F5

Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration.

Footnote F6

The shares subject to the option are fully vested and immediately exercisable.

Footnote F7

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.

Footnote F8

The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .